Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

Edward M Vital, Raj Tummala, Eric F. Morand et al.|Annals of the Rheumatic Diseases|2022

Cited by 141